|
|
|
Upcoming CURE Funding Deadlines
Upcoming deadline!! NIH Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)
Supports postdoctoral scientists from diverse backgrounds conducting research in areas within the NIGMS mission by providing up to 5 years of support in two phases. The initial (K99) phase provides support for up to 2 years of mentored postdoctoral research training and career development. The second (R00) phase provides up to 3 years of independent research support once the scholar transitions to an independent faculty position. Awardees must be US Citizens or Permanent Residents. For more information see: PAR-19-343. Please note, the first application deadline is February 12, 2020. Intramural postdocs are eligible for this award. For additional information on both funding announcements, please see the MOSAIC website.
Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) | PAR-18-655 | Applications are due June 18 and Nov. 19, 2020.
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) | PAR-18-731 | Application are due June 18 and Nov. 19, 2020.
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) | PAR-18-654 | Application are due June 18 and Nov. 19, 2020.
More CURE Funding Opportunities (Downloadable PDF)
Upcoming Non-CURE Funding Opportunities
Upcoming deadline!! The Sexual & Gender Minority Research Office (SGMRO) is pleased to announce the publication of a Notice of Special Interest (NOSI) regarding Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (NOT-OD-20-032).
This Notice of Special Interest (NOSI) announces the availability of administrative supplements to provide funding for the expansion of existing research projects to incorporate sexual and gender minority (SGM) populations, which include, but are not limited to, those populations described in Notice NOT-OD-19-139. Basic, social, behavioral, clinical, translational, and health services research relevant to the missions of the sponsoring NIH Institutes or Centers (ICs) may be proposed in response to this solicitation. Potential applicants are also encouraged to review the FY 2017 Portfolio Analysis of NIH-funded SGM research to identify potential research gaps that may be relevant to this NOSI.
Application Due Dates are January 31, 2020 for FY 2020, January 25, 2021 for FY 2021, by 5:00 PM local time of applicant organization.
Administrative Supplements to Support Cancer Disparity Collaborative Research | Due dates: February 10, 2020 and September 10, 2020
Description: If you hold an active NCI-funded R01 (with at least 2 years of support remaining) and are interested in expanding your research to incorporate a cancer disparities research project, please consider submitting a proposal under FOA PA-18-842: Administrative Supplements to Support Cancer Disparity Collaborative Research. Please note that for this FOA, collaborative teams are required between a non-cancer disparities investigator (PI of the R01) and a collaborator who has minority health research or cancer disparities research expertise.
Co-infection and Cancer (R01/R21 Clinical Trial Not Allowed) | PAR-20-062 | PAR-20-061
Applications are due March 6, 2020. The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection.
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | PAR-18-869 | Application due date March 6, 2020; November 6, 2020; March 8, 2021
Expiration Date: September 11, 2020
New!! Alzheimer’s-focused Administrative Supplements for NIH/NCI Grants that are not focused on Alzheimer’s Disease (NOT-CA-20-019 and related announcements NOT-AG-20-008 and PA-18-591): Applications due March 6, 2020
Parent grant program directors need to be involved in the process with the PIs applying to this supplement. Grantees cannot have large carryovers and must have one year or more left on their grants. Administrative supplements are due March 6 and are one-year supplements.
New!! Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01/R21 Clinical Trials Not Allowed) | Applications due April 1, 2020 | PAR-20-088 | PAR-20-081
The purpose of the initiative is to support multidisciplinary exploratory or developmental research to understand the underlying etiologic factors and mechanisms that contribute to population-level disparities in chronic liver diseases and liver cancer in the U.S.
New!! Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01/R21 Clinical Trial Optional) | Applications due April 30, 2020 | RFA-CA-20-004 | RFA-CA-20-005
The current issuance of the PQ Initiative includes an updated set of 9 PQs. Each research project proposed in response to this FOA must be focused on addressing the research problems defined by a specific PQ selected from the list. Projects proposed to address PQs may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged if they serve the scientific focus of the selected PQ.
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01/R21 Clinical Trial Optional) | PA-18-738 | PA-18-739 | Application Due: Standard dates apply.
Expiration Date: May 8, 2021
FOA for Building Population Health Research Capacity in the U.S. Affiliated Pacific Islands
Very little information regarding the specific health status of U.S.-Affiliated Pacific Islands (USAPI) populations is available. There is a critical need to collect basic epidemiological and health services data for USAPI populations residing in the region. NIMHD is supporting a new funding opportunity to build local organizations’ capacity to conduct ongoing population health research in the USAPI. The funding will support population health research projects that will provide novel data for USAPI populations and serve as the foundation for future research efforts. Click here to learn more.
Open Date (Earliest Submission Date): June 15, 2020
Application Due Date: July 15, 2020, by 5:00 p.m. local time of applicant organization
More Non-CURE Funding Opportunities (Downloadable PDF)
NCI's Healthcare Delivery Research Program (HDRP) Funding Opportunities
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21/R01 Clinical Trial Not Allowed) | Applications are due March 4, 2020, March 4, 2021 | PAR-19-019 | PAR-19-018
Purpose: The purpose of this initiative is to promote multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations.
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20, Clinical Trials Optional) | Application are due June 19, 2020, and October 18, 2020 | RFA-CA-19-034
Purpose: The goals for this FOA include developing translational research programs focused on investigating cancer disparities. The P20 grants will support feasibility and planning activities to build cancer disparities research programs, with the expectation that the research programs will become competitive for a full P50 SPORE. Reissue of RFA-CA-17-034 (resubmissions will be accepted). New restrictions: Due to a focus on understudied areas of cancer disparities, applications proposing prostate and breast cancer projects are not responsive for this issuance.
More HDRP Funding Opportunities (Downloadable PDF)
Other Funding Opportunities
New!! The Food and Drug Administration (FDA) solicits for advanced research and development proposals to support regulatory science and innovation.The FDA anticipates that research and development activities awarded under this BAA will serve to advance scientific knowledge to accomplish its mission to protect and promote the health of our nation. To learn more: https://beta.sam.gov/opp/1c2db86ed5b2440a9ef5b4fc2d5a5c09/view
White papers due no later than 5:00 pm, Eastern Standard Time, March 2, 2020, and earlier if possible. White papers submitted after that date will still be accepted, but due to a lack of lead time, will not be considered for award in FY20.
New!! CDC Partnerships to Increase Colorectal Cancer Screening | Application due March 17, 2020 | CDC-RFA-DP20-2002
The Centers for Disease Control and Prevention (CDC) will make 35 awards from a total investment of $110 million to increase colorectal cancer screening among populations aged 50-75 with low screening rates. Eligible applicants include state and local governments, public and private institutions of higher education, nonprofit organizations and Native American tribal organizations. A 2017 report from the CDC indicated higher rates of mortality among rural regions for certain preventable cancers, including colorectal.
New!! New Federal Funding Opportunity for the Black Lung Clinics Program and Black Lung Data and Resource Center Program
The Health Resources and Services Administration (HRSA) published the Notice of Funding Opportunity (NOFO) for the FY 2020 Black Lung Clinics Program (BLCP).The purpose of this program is to reduce the morbidity and mortality associated with occupationally-related coal mine dust lung disease through the provision of quality medical, outreach, educational, and benefits counseling services for active, inactive, retired, and disabled US coal miners. The FY 2020 BLCP NOFO reflects current disease trends and incorporates language around Coal Workers’ Pneumoconiosis and Progressive Massive Fibrosis to increase educational and outreach activities and promote early detection. The NOFO also extends the competitive cycle from three years to five years and requires patient-level data reporting. This will allow HRSA to longitudinally track disease progression in miner patients to better inform medical, outreach, educational, and benefits counseling services provided. It is anticipated that up to 15 grant awards will be made.
Also published today is the NOFO for the Black Lung Data and Resource Center (BLDRC) which is focused on strengthening the operations of BLCP recipients through programmatic assistance and improved data collection and analysis related to the health status and needs of U.S. coal miners. It is anticipated that up to one cooperative agreement award will be made.
Full details on both programs and requirements for applicants are available at Grants.gov. For questions about either program, contact Krista M. Mastel at blacklung@hrsa.gov. The application deadline is March 6, 2020.
NIMHD Supports the Research Centers in Minority Institutiosn (RCMI) Program | NOT-MD-20-012
NIMHD is supporting an upcoming funding opportunity under the Research Centers in Minority Institutions (RCMI) program. Funding will support specialized research centers in institutions that offer doctoral degrees in the health professions or health-related sciences and have a commitment to educating students from underrepresented populations and in institutions that provide health care services to medically underserved communities.
NIMHD encourages investigators to participate in this important public health activity and welcomes inquiries concerning this funding opportunity. Review the upcoming funding opportunity announcement (FOA) for more information on eligibility and application submissions.
Estimated Publication Date of FOA: February 14, 2020
Estimated Deadline: April 14, 2020
Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE-2) (R61/R33 - Clinical Trial Required)
This FOA invites applications for single-site, biphasic, late-stage implementation and translation (T4) research trials to identify and test pragmatic and sustainable implementation strategies that will increase the use of evidence-based practices (EBP) for preventing and/or managing heart, lung, and blood diseases and/or sleep (HLBS) disorders. RFA-HL-21-011
Application Due: May 1, 2020
New NIH "FORMS-F" Grant Application Forms and Instructions Coming for Due Dates on or after May 25, 2020
This notice states that the following application forms include substantive changes (i.e., new/deleted/modified fields). All other forms include only an OMB expiration date change. NOT-OD-20-026
- PHS 398 Career Development Award Supplemental Form
- PHS 398 Cover Page Supplement
- PHS Assignment Request form
- PHS Fellowship Supplemental Form
- PHS Human Subjects and Clinical Trials Information
- SBIR/STTR Information
Notice of Intent to Publish a Funding Opportunity Announcement for Strengthening Institutional Capacity to Conduct Global Cancer Research (D43)
The NCI intends to publish a FOA inviting applications from U.S.-based cancer-research intensive institutions who propose research training programs working in collaboration with a low-and middle-income country (LMIC) institution to strengthen capacity to conduct global research. NOT-CA-20-015
Additional Resources
Standard Application Deadlines: For more on standard applications deadlines visit: https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm Program staff are available to answer questions. Contact information and funding resources are available online.
Sample Grant Applications: The National Cancer Institute (NCI) frequently receives questions from investigators for examples of successfully funded grant applications. Several investigators and their organizations agreed to let the Division of Cancer Control & Population Sciences (DCCPS) programs post excerpts of their grant applications online.
|
|
New!! 2020 Biomedical Science Careers Student Conference | The Westin Copley Place in Boston, Massachusetts | Friday, April 3 and Saturday, April 4, 2020
BSCP will hold its fifteenth biennial Biomedical Science Careers Student Conference for postdocs (research and clinical); medical, dental and graduate students; post-baccalaureates; college and community college students; and high school seniors and juniors (particularly African-American, Hispanic/Latino or American Indian/Alaska Native students/fellows).
The aim of the Conference is to provide students/fellows with an opportunity to network with advisors/role models from the basic and clinical sciences, medicine, public health, academia and the biopharmaceutical industry. Please see attached flyer for more information. There is no fee to attend, but completion of a four-page application is required. Interested students should contact Hollie DeSilva at hollie_desilva@hms.harvard.edu to request an application. Application Deadline: February 4, 2020.
Association for Prevention Teaching and Research (APTR) | March 2- 4, 2020 | San Antonio
APTR invites abstract submissions to present at Teaching Prevention 2020: Fostering Population Health and Advancing Prevention Science. Please learn more here.
4th Annual Cancer Disparities Symposium: Cultivating Science and Community Engagement to Address Cancer Health Disparities | March 6, 2010
Hosted by the Office of Cancer Disparities Research and P20 Cancer Health Disparities SPORE
The symposium will feature keynote presentations by renowned disparities researchers and community leaders, a poster session highlighting academic research and community programs, networking session and an interactive panel discussion. Register to attend.
The 2020 conference, titled "The Evidence of personal and Societal Determinants to Achieve Health Equity," will address the many complex factors including where we live, our environment, genetics, income and education. Please learn more here.
New!! Save-the-Date: 2020 Health Disparities Research Institute
The National Institute on Minority Health and Health Disparities (NIMHD) will host the Health Disparities Research Institute (HDRI) from August 3-7, 2020, in Bethesda, MD. The online application system will open in early February 2020! The HDRI aims to support the research career development of promising early-career minority health and health disparities research scientists and to stimulate research in disciplines supported by health disparities science. Institute participants will also have the opportunity to engage in sessions with NIH scientific staff involved in health disparities research across the various NIH institutes and centers. Please note that applications will only be accepted from extramural scientists who meet NIH’s Early Stage Investigator ( ESI) eligibility criteria. NIH and HHS staff, including persons doing fellowships/training at NIH or an HHS agency, are not eligible to apply.
Visit the HDRI webpage to learn more about the target audience, eligibility, selection criteria, and how to apply. For questions or more information, email HDRI@nih.gov. |
|
Upcoming!! 5th Annual Graduate Student Recruiting Program (GSRP) Now Accepting Applications
NCI is currently recruiting senior-level graduate students for our 5th Annual GSRP. The GSRP is a competitive program that provides students the opportunity to explore postdoctoral fellowships at the NCI. During the program in May, accepted applicants will visit the NIH, learn about the various resources that NIH and NCI have to offer, and network with NCI investigators, staff, and current postdocs. Graduate students who apply and are invited to visit NIH have a distinct advantage, so please distribute this information to your network! Application Due Date January 31, 2020.
We strongly encourage under-represented minorities to submit applications. NCI is committed to training the next generation of scientific leaders, and it is crucial that this reflects the diversity of the population it serves. Additional information can be found by visiting the GSRP website. Should you need any further information, please do not hesitate to contact the GSRP coordinator.
Upcoming!! Washington Student Achievement Council: American Indian Endowed Scholarship. Provides financial assistance to low-income Washington State students who have close social and cultural ties to an American Indian Tribe or community within the state. Application period ends February 1, 2020. Learn more.
Upcoming!! NCI-sponsored Systems Biology and Physical Oncology Undergraduate Summer Research Opportunity
The National Cancer Institute’s (NCI) Cancer Systems Biology Consortium and Physical Sciences in Oncology Network are offering rising Junior and Senior undergraduates with outstanding research potential the opportunity to work closely with faculty mentors from NCI-supported institutions for a 10-week summer fellowship. The 2020 summer research program is designed specifically for students to gain experience in the interdisciplinary fields of systems biology and physical oncology. Students who are especially interested in cancer research careers are encouraged to apply.
Applications due February 7, 2020. The website for the 2020 NCI CSBC/PS-ON Summer Research Program is now live and accepting applications.
HHS/Indian Health Service (IHS): IHS Scholarship Program. This program offers three scholarships for undergraduate and graduate AI/AN students in order to educate and train health professionals to staff Tribal health programs. Application period ends Feb. 28, 2020, 7:00 PM (ET). Learn more.
New!! 2020 Éxito! Latino Cancer Research Leadership Training program & $3,250 internships from the Institute for Health Promotion Research (IHPR) at UT Health San Antonio
Each year, the Éxito! program recruits 25 U.S. master’s level students and professionals to participate in a five-day, culturally tailored Éxito! summer institute to promote pursuit of a doctoral degree and cancer research.The next Éxito! summer institute is set for June 1-5, 2020 in San Antonio. Participants will interact with Latino researchers, mentors, and doctoral experts to learn about Latino cancer, succeeding in a doctoral program, and the diversity of careers in cancer research. Ten optional internships also are available to program participants.
Applications are due by 11:59 p.m. CST, Monday, March 2, 2020.
The Scientist Mentoring & Diversity Program (SMDP) is accepting applications from ethnically diverse students for the 2020 SMDP. To learn more, click here. Interested candidates are invited to apply online at http://smdp.icpdprograms.org/. Successful student applicants will receive fellowships to attend one of the programs and virtually all expenses for the one-year SMDP are covered. We are now accepting applications. Special consideration is given to how many weeks prior to the April 3, 2020, deadline students apply.
American Indian College Fund: Full Circle Scholarship. Provides financial assistance to AI/AN students seeking undergraduate and graduate degrees at Tribal colleges/universities or nonprofit schools. Application period ends May 31, 2020. Learn more.
New!! NCI CRCHD Professional Development Workshop and Mock Review
SAVE THE DATE! June 8-9, 2020 | Bethesda North Marriott Hotel and Conference Center
The National Cancer Institute (NCI) Center to Reduce Cancer Health Disparities (CRCHD) will host its annual 2020 Professional Development Workshop and Mock Review (PDW & MR) on Monday, June 8, and Tuesday, June 9, 2020.
The purpose of the PDW & MR is to share information and experiences with recipients of CRCHD training awards and to assist with career development and advancement in cancer and cancer health disparities research. CRCHD-supported graduate students, postdocs, and early-career investigators are strongly encouraged to attend. As a reminder, K awardees are required to attend the PDW & MR at least two times during the duration of their award.
For questions regarding meeting logistics, please contact the contractor assisting CRCHD, Ms. Michelle Murray, at conferences@novaresearch.com. For questions regarding the Program, please contact CRCHD Program Directors Dr. John Ojeifo, ojeifojo@mail.nih.gov, or Dr. Jessica Calzola, Jessica.calzola@nih.gov.
|
|
The American Association for Cancer Research (AACR) is the oldest and largest scientific organization in the world focused on every aspect of high-quality, innovative cancer research. Committed to building and training a diverse cancer research workforce, the AACR invests in the training of the next generation of cancer researchers and early-career investigators by offering the following Educational Workshops in 2020.
AACR/ASCO Methods in Clinical Cancer Research Workshop (Vail, CO)
Clinical fellows and junior faculty level clinical investigators will learn the essentials of effective clinical trial design and discuss the full spectrum of challenges and opportunities in clinical cancer research.
Application deadline: Tuesday, March 17, 2020
For more information: www.aacr.org/mccrus20 | Contact: Kathryn Leonard (kathryn.leonard@aacr.org)
Molecular Biology in Clinical Oncology Workshop (Snowmass Village, CO)
Physicians or clinical oncology fellows in any subspecialty with the intent of a career as a physician-scientist will be guided in the principles of designing scientific experiments based on examples from faculty, grant writing, and hands-on laboratory techniques.
Application deadline: Monday, March 30, 2020
For more information: www.aacr.org/mbco20 | Contact: Amy Baran (amy.baran@aacr.org)
Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine (Boston, MA)
Molecular epidemiologists, geneticists, statisticians, bioinformaticians, molecular biologists, physician-scientists, and others who have completed basic coursework in epidemiology will be trained in the integration of biology and epidemiology in studies of cancer etiology and disease outcome.
Application deadline: Monday, April 13, 2020
For more information: www.aacr.org/ime20 | Contact: Shakira Nelson (shakira.nelson@aacr.org)
Translational Cancer Research for Basic Scientists Workshop (Boston, MA)
Basic scientists at the pre- or postdoctoral level and early-career scientists will gain an in-depth understanding of translational research, enabling the adaptation of their research for maximum clinical impact and transition into translational cancer medicine.
Application deadline: Thursday, May 7, 2020
For more information: www.aacr.org/tcr20 | Contact: Lyngine Calizo (lyngine.calizo@aacr.org)
|
|
|
Scientific Positions at NIH
As the steward of medical and behavioral research for the Nation, the NIH scientific community encompasses diverse biomedical professionals involved in direct patient care activities, research, and/or scientific administrative roles. Scientific positions at the NIH include nurse researcher, physician-scientist, clinical and basic researchers, and data scientists. Additionally, the NIH supports the next generation of scientists, funding thousands of graduate students and postdoctoral fellows across the United States. Please learn more here.
New!! NIMHD is Recruiting Physicians | Application open and close Dates: 01/28/2020 to 02/06/2020
Are you a leader in clinical and health services research focused on minority health and healthcare disparities? The National Institute on Minority Health and Health Disparities (NIMHD) is recruiting for multiple Physician positions with responsibility for supporting and/or developing initiatives that investigate clinical and social factors research for the institute. NIMHD’s mission is to provide a national platform for the Federal effort to advance knowledge and understanding of mechanisms to improve minority health, identify and understand health disparities, and develop effective interventions to reduce these disparities in community and clinical settings. Please learn more here.
New!! Associate/Full Professor
Morgan State University (MSU) in the School of Computer of Computer, Mathematical and Natural Sciences (SCMNS) has a faculty position for an accomplished basic biomedical researcher with experience in health disparities research. The faculty member is expected to be an anchor on campus to strengthen urban health and health disparities research, the faculty member will assume the role of Deputy Director for the newly established Center for Urban Health Disparities Research and Innovation (RCMI@Morgan) funded by the National Institutes of Health. S/he will be provided with start-up funds, facilities and access to equipment to be a successful researcher and obtain R01-equivalent federal funding at MSU. Other expectations are as follows:
- Be the Deputy Director of the RCMI@Morgan Center to assist the Principal Investigator (PI) on all aspects of the project;
- Establish an externally funded basic biomedical research program at MSU with an emphasis on health disparities;
- Mentor junior faculty members, postdoctoral fellows and students in research, including grant writing, networking and publishing;
- Strengthen research relationships between MSU and other research institutions, especially Johns Hopkins University and the University of Maryland, Baltimore;
- Collaborate with other researchers on campus who have health disparities/urban health research interests;
- Teach undergraduate and graduate courses.
Qualifications:
- A terminal degree (PhD or equivalent) matching one of the five departments (Biology, Chemistry, Computer Science, Mathematics or Physics & Engineering Physics) to be appointed as a tenure-track or tenured associate or full professor;
- A high level of expertise in basic biomedical research in the area of health disparities;
- An outstanding track record of academic accomplishments evidenced by publications and federal research grants (NIH R01-equivalent);
- Interested and experienced in mentoring junior faculty, postdoctoral fellows and students.
Applicants should submit a statement letter, a curriculum vita, a detailed research plan, and names of 3-5 scientists who knows the applicant’s scientific accomplishment, work ethic and personality to the search committee chair: Dr. Farin Kamangar, Morgan State University, Richard Dixon 200, Baltimore, MD 21252. Email: farin.kamangar@morgan.edu; Phone 443-885-4515.
More Career Opportunities & Resources
|
|
|
Resources
New!! Method for Cancer Diagnosis
Clinical Proteomics Tumor Analysis Consortium (CPTAC) investigators from the Baylor College of Medicine and the Broad Institute have developed a method to perform a panel of high quality multi-omics analysis using less tissue than before. Armed with a single needle core biopsy, researchers examined small amounts of breast tumor tissue from patients before and after ErbB2 targeting chemotherapy using genomics, proteomics and phosphoproteomics. Please click here to find out more.
New Findings hint at therapies for African Americans with lung cancer
A study published in Nature Communications reveals that two genes tend to be mutated at higher rates in cancerous lung tissue samples taken from African Americans, hinting that these patients may benefit more from certain therapies targeting those genes. Please learn more here.
Oncofertility: Creating a Bridge Between Cancer Care and Reproductive Health
Dr. Teresa Woodruff discusses the field that connects oncology with reproductive health, and the Oncofertility Consortium’s efforts to support clinicians, cancer patients, and families in understanding how cancer and its treatment affect fertility. Please learn more here.
Visit the GMaP Group for additional tools and resources for researchers, such as links to biospecimens, biorepositories, and statistician tools!
News
Insurance Status Helps Explain Racial Disparities in Cancer Diagnosis
Women have the best odds of surviving breast cancer if their disease is caught at an early stage, when treatments are most likely to succeed. Major strides have been made in the early detection of breast cancer in recent years. But not all populations have benefited equally, with racial and... Please read more here.
Side effects of CAR T-cell therapy are dramatically reduced with new receptor
A new immunotherapy for lymphoma has been found to cause lower levels of neurologic toxicity than other T-cell therapies for lymphoma. The findings come from the first clinical test of a CAR T-cell therapy using a new anti-cancer T-cell receptor developed in the Center for Cancer Research. Please read more here.
Disparities in Care, Patient-Reported Outcomes, and Blood-Based Testing: Research from 2020 Gastrointestinal Cancers Symposium
The researchers found that young adults with colorectal cancer who lived in areas with the lowest income and lowest education had a 24% higher risk of dying than those who lived in areas with the highest income and education. Further analysis showed that those who lived in urban areas had a 10% higher risk of death than those from metropolitan areas, regardless of the area’s median income. People diagnosed with stage IV cancer in the lowest income areas had worse overall survival than those who lived in areas with higher incomes. The people in the areas with the lowest income were more likely to be black, to not have private health insurance, to have other health problems or diseases, and to have been diagnosed with a more advanced cancer. Please read more here.
Genomic Profiles of Lung Cancer Differ Based on Ancestry
An analysis of tumors from people with non-small cell lung cancer by researchers at the Center for Cancer Research revealed differences in genomic instability and homologous recombination deficiency in tumors from people with African ancestry compared to those with European ancestry. Please learn more here.
Additional news and a list of newsletters are available on our news page.
|
|
Screen to Save
This CRCHD initiative aims to increase colorectal screening rates among racial and ethnic minority communities nationwide. Working through the NCI-supported National Outreach Network, community health educators (CHEs) will provide culturally tailored, evidence-based colorectal cancer information, education, and screening resources within underserved populations.
Visit Screen to Save to learn more about this initiative.
|
|
|
Additional news and a list of newsletters are available on our news page.
|
|
|
|
